Trial intelligence / Profile preview

Remimazolam versus propofol for postoperative delirium after hip surgery

ChiCTR2000038223Phase 4Recruiting

Sponsor
First Affiliated Hospital of Anhui Medical University
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of remimazolam and propofol in postoperative delirium (POD) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Postoperative delirium incidence within 1 day after surgery, Postoperative delirium incidence within 2 days after surgery and 1 more. Started Jun 2021; status: recruiting.

02

Drugs

remimazolampropofol
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2000038223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call